4.5 Article

Vps34 Inhibits Hepatocellular Carcinoma Invasion by Regulating Endosome-Lysosome Trafficking via Rab7-RILP and Rab11

期刊

CANCER RESEARCH AND TREATMENT
卷 54, 期 1, 页码 182-198

出版社

KOREAN CANCER ASSOCIATION
DOI: 10.4143/crt.2020.578

关键词

Key words Cell invasion; Vesicular transportation; Endocytosis; Endosome-lysosome system; Juxtanuclear lysosome aggregation; Lysosomal trafficking; Rab7; RILP; Recycling endosome; Rab11

类别

向作者/读者索取更多资源

This study reveals that Vps34 acts as an invasion suppressor in hepatocellular carcinoma (HCC) cells. Vps34 can promote lysosomal juxtanuclear accumulation, leading to a reduction in HCC cell invasion through the Rab7-RILP pathway. Additionally, the deficiency of Vps34 in HCC cells affects the endosome-lysosome system, resulting in enhanced Rab11-mediated endocytic recycling of cell surface receptors and increased HCC cell invasion.
Purpose The role of vacuolar protein sorting 34 (Vps34), an indispensable protein required for cell vesicular trafficking, in the biological behavior of hepatocellular carcinoma (HCC) has yet to be studied. Materials and Methods In the present study, the expression of Vps34 in HCC and the effect of Vps34 on HCC cell invasion was detected both in vivo and in vitro. Furthermore, by modulating the RILP and Rab11, which regulate juxtanuclear lysosome aggregation and recycling endosome respectively, the underlying mechanism was investigated. Results Vps34 was significantly decreased in HCC and negatively correlated with the HCC invasiveness both in vivo and in vitro. Moreover, Vps34 could promote lysosomal juxtanuclear accumulation, reduce the invasive ability of HCC cells via the Rab7-RILP pathway. In addition, the deficiency of Vps34 in HCC cells affected the endosome-lysosome system, resulting in enhanced Rab11 mediated endocytic recycling of cell surface receptor and increased invasion of HCC cells. Conclusion Our study reveals that Vps34 acts as an invasion suppressor in HCC cells, and more importantly, the endosome-lysosome trafficking regulated by Vps34 has the potential to become a target pathway in HCC treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据